Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes.
Mucopolysaccharidosis type VI, or Maroteaux-Lamy syndrome, is a lysosomal storage disorder caused by a deficiency of the enzyme arylsulfatase B (ASB), also known as N-acetylgalactosamine-4-sulfatase. Multiple clinical phenotypes of this autosomal recessively inherited disease have been described. Recent isolation and characterization of the human ASB gene facilitated the analysis of molecular defects underlying the different phenotypes. Conditions for PCR amplification of the entire open reading frame from genomic DNA and for subsequent direct automated DNA sequencing of the resulting DNA fragments were established. Besides two polymorphisms described elsewhere that cause methionine-for-valine substitutions in the arylsulfatase B gene, six new mutations in six patients were detected: four point mutations resulting in amino acid substitutions, a 1-bp deletion, and a 1-bp insertion. The point mutations were two G-to-A and two T-to-C transitions. The G-to-A transitions cause an arginine-for-glycine substitution at residue 144 in a homoallelic patient with a severe disease phenotype and a tyrosine-for-cysteine substitution at residue 521 in a potentially heteroallelic patient with the severe form of the disease. The T-to-C transitions cause an arginine-for-cysteine substitution at amino acid residue 192 in a homoallelic patient with mild symptoms and a proline-for-leucine substitution at amino acid 321 in a homoallelic patient with the intermediate form. The insertion between nucleotides T1284 and G1285 resulted in a loss of the 100 C-terminal amino acids of the wild-type protein and in the deletion of nucleotide C1577 in a 39-amino-acid C-terminal extension of the ASB polypeptide. Both mutations were detected in homoallelic patients with the severe form of the disease. Expression of mutant cDNAs encoding the four amino acid substitutions and the deletion resulted in severe reduction of both ASB protein levels and arylsulfatase enzyme activity in comparison with a wild-type control. The six mutations described in the present study were unique among 25 unrelated mucopolysaccharidosis VI patients, suggesting a broad molecular heterogeneity of the Maroteaux-Lamy syndrome.
Isbrandt
D
D
Biochemie II, Universität Göttingen, Germany.
Arlt
G
G
Brooks
D A
DA
Hopwood
J J
JJ
von Figura
K
K
Peters
C
C
D000483:Alleles; D000595:Amino Acid Sequence; D000818:Animals; D001120:Arginine; D001483:Base Sequence; D002460:Cell Line; D002478:Cells, Cultured; D002675:Child, Preschool; D002803:Chondro-4-Sulfatase / Q000096:biosynthesis / Q000235:genetics*; D002874:Chromosome Mapping; D003241:Consanguinity; D003545:Cysteine; D004247:DNA / Q000235:genetics; D017931:DNA Primers; D004251:DNA Transposable Elements; D005091:Exons; D005260:Female; D006801:Humans; D007223:Infant; D007930:Leucine; D008297:Male; D008969:Molecular Sequence Data; D009087:Mucopolysaccharidosis VI / Q000201:enzymology* / Q000235:genetics*; D010641:Phenotype; D017354:Point Mutation; D016133:Polymerase Chain Reaction / Q000379:methods; D011110:Polymorphism, Genetic; D011392:Proline; D015183:Restriction Mapping; D017384:Sequence Deletion; D014162:Transfection
D017931:DNA Primers; D004251:DNA Transposable Elements; D004247:DNA; D001120:Arginine; D011392:Proline; D002803:Chondro-4-Sulfatase; D007930:Leucine; D003545:Cysteine